Company Analysis
Sign in

Arcus Biosciences, Inc. (RCUS)

NYSE: RCUS · Pharmaceutical Preparations · Hayward, CA · filing with the SEC since 2017
Full chart Alerts Compare
Grade4.7
◀ Past 5.3● Present 4.9▶ Future 3.8
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedFeb 25, 2026Feb 25, 2025Feb 21, 2024Feb 28, 2023Feb 23, 2022Feb 25, 2021Mar 5, 2020Mar 5, 2019··
Revenue33,00051,00037,000r38,000r383,000r78,000r15,0008,3531,413·
For lenders
Provision for credit losses0000000···
Research and development523,000448,000340,000288,000257,000r159,000r78,48149,64647,21814,247
General and administrative110,000120,000117,000104,00072,000r43,000r25,22813,5667,6363,935
Total operating expenses633,000588,000457,000392,000329,000r202,000r103,70963,21254,85418,182
Operating income-386,000-330,000-340,000-280,00054,000r-124,000r-88,709-54,859-53,441-18,182
Interest expense8,0004,0002,0002,000······
Share of profit of equity-method investments·····-613-1,202-886-4160
Total non-operating income (expense)33,00048,00039,00014,0001,000r1,000r3,9995,265359212
Income before income taxes-353,000-282,000-301,000-266,00055,000r-123,000r-84,710···
Income tax expense01,0006,0001,0002,000r·····
Net income including non-controlling interests-353,000-283,000-307,000-267,00053,000r-123,000r-84,710-49,594-53,082-17,970
Net income-353,000-283,000-307,000-267,00053,000r-123,000r-84,710-49,594-53,082-17,970
Earnings per share, basic-3.29-3.14-4.15-3.710.76-2.24-1.93···
Earnings per share, diluted-3.29-3.14-4.15-3.710.71-2.24-1.93···
Earnings per share, basic and diluted·····-2.24-1.93-1.43-29.03-20.80
Weighted average shares, basic107,400,00090,100,00074,000,00072,000,00069,300,000r54,800,000r43,825,991r36,357,3363,885,5083,374,609
Weighted average shares, diluted107,400,00090,100,00074,000,00072,000,00074,000,000r54,800,000r43,825,991···
Weighted average shares, basic and diluted·····54,787,11843,825,99134,618,2371,828,262863,983
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues
Provision for credit losses set aside for loans that may not be repaidus-gaap:ProvisionForLoanLossesExpensed
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton RCUS · research, not advice